Cynata Therapeutics Ltd banner

Cynata Therapeutics Ltd
ASX:CYP

Watchlist Manager
Cynata Therapeutics Ltd Logo
Cynata Therapeutics Ltd
ASX:CYP
Watchlist
Price: 0.285 AUD -1.72% Market Closed
Market Cap: AU$67.7m

Income Statement

Earnings Waterfall
Cynata Therapeutics Ltd

Income Statement
Cynata Therapeutics Ltd

Rotate your device to view
Income Statement
Currency: AUD
Jun-2009 Dec-2009 Jun-2010 Dec-2010 Jun-2011 Dec-2011 Jun-2012 Dec-2012 Jun-2013 Dec-2013 Jun-2014 Dec-2014 Jun-2015 Dec-2015 Jun-2016 Dec-2016 Jun-2017 Dec-2017 Jun-2018 Dec-2018 Jun-2019 Dec-2019 Jun-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025 Dec-2025
Revenue
Interest Expense
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Revenue
0
N/A
0
N/A
0
N/A
0
N/A
0
+169%
0
N/A
0
-9%
0
-25%
0
-71%
0
-71%
0
N/A
0
N/A
0
N/A
0
N/A
0
+85%
0
-32%
0
-6%
0
+56%
0
-3%
0
+36%
0
0%
0
-48%
0
-35%
0
-5%
0
+27%
7
+8 702%
7
0%
0
-97%
0
+98%
0
+24%
0
-4%
0
-35%
0
-16%
0
-11%
Gross Profit
Cost of Revenue
(0)
0
(0)
(0)
(0)
(1)
(1)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Gross Profit
(0)
N/A
0
N/A
(0)
N/A
(0)
+12%
(0)
+87%
(0)
-375%
(0)
-5%
(0)
-5%
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
0
N/A
Operating Income
Operating Expenses
(2)
(2)
(2)
(2)
(3)
(2)
(1)
(0)
(1)
(2)
0
(3)
(4)
(6)
(6)
(6)
(6)
(6)
(5)
(6)
(9)
(8)
(4)
(6)
(8)
(11)
(13)
(10)
(15)
(14)
(10)
(9)
(10)
(9)
Selling, General & Administrative
(2)
(1)
(2)
(1)
(2)
(0)
(1)
(0)
(1)
(1)
0
(1)
(1)
(1)
(1)
(1)
(1)
(1)
(3)
(2)
(4)
(3)
(4)
(5)
(5)
(5)
(5)
(4)
(4)
(4)
(4)
(4)
(4)
(4)
Research & Development
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
(0)
(0)
0
(1)
(2)
(4)
(4)
(3)
(3)
(4)
(3)
(4)
(6)
(8)
(6)
(4)
(4)
(7)
(9)
(8)
(12)
(13)
(9)
(7)
(7)
(6)
Depreciation & Amortization
(0)
0
0
0
(0)
(0)
(0)
(0)
0
0
0
0
(0)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
Other Operating Expenses
0
(1)
0
(1)
0
(2)
0
(1)
0
(1)
0
(0)
(0)
(1)
(1)
(1)
(1)
(0)
1
(0)
1
3
7
3
1
0
1
3
2
2
2
2
2
2
Operating Income
(2)
N/A
(2)
-25%
(2)
-2%
(2)
-4%
(3)
-10%
(2)
+23%
(2)
+20%
(0)
+79%
(1)
-148%
(2)
-179%
0
N/A
(3)
N/A
(4)
-47%
(6)
-47%
(6)
0%
(5)
+10%
(6)
-16%
(5)
+14%
(5)
+14%
(6)
-23%
(9)
-49%
(8)
+7%
(3)
+57%
(6)
-74%
(8)
-27%
(4)
+51%
(6)
-63%
(10)
-67%
(15)
-45%
(14)
+4%
(10)
+29%
(9)
+9%
(9)
-5%
(8)
+11%
Pre-Tax Income
Interest Income Expense
0
(0)
(0)
(0)
(0)
0
0
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
(0)
1
1
0
0
0
0
(0)
0
Non-Reccuring Items
0
0
0
0
0
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Total Other Income
0
0
0
0
0
0
0
0
0
(0)
0
0
0
1
1
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Pre-Tax Income
(1)
N/A
(2)
-41%
(2)
-10%
(2)
-4%
(3)
-11%
(3)
-10%
(2)
+44%
(0)
+79%
(1)
-179%
(2)
-147%
0
N/A
(3)
N/A
(4)
-36%
(5)
-28%
(5)
-4%
(3)
+29%
(5)
-30%
(5)
-17%
(5)
+15%
(6)
-26%
(8)
-48%
(8)
+5%
(4)
+55%
(6)
-63%
(8)
-30%
(4)
+48%
(5)
-37%
(9)
-74%
(14)
-50%
(14)
+4%
(10)
+29%
(9)
+9%
(9)
-6%
(8)
+11%
Net Income
Tax Provision
0
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Income from Continuing Operations
(1)
(2)
(2)
(2)
(3)
(3)
(2)
(0)
(1)
(2)
0
(3)
(4)
(5)
(5)
(3)
(5)
(5)
(5)
(6)
(8)
(8)
(4)
(6)
(8)
(4)
(5)
(9)
(14)
(14)
(10)
(9)
(9)
(8)
Net Income (Common)
(1)
N/A
(2)
-47%
(2)
+0%
(2)
-4%
(3)
-16%
(3)
-10%
(2)
+45%
(0)
+81%
(1)
-217%
(2)
-147%
0
N/A
(3)
N/A
(4)
-36%
(5)
-28%
(5)
-4%
(3)
+29%
(5)
-30%
(5)
-17%
(5)
+15%
(6)
-26%
(8)
-48%
(8)
+5%
(4)
+55%
(6)
-63%
(8)
-30%
(4)
+48%
(5)
-37%
(9)
-74%
(14)
-50%
(14)
+4%
(10)
+29%
(9)
+9%
(9)
-6%
(8)
+11%
EPS (Diluted)
-0.39
N/A
-0.54
-38%
-0.5
+7%
-0.38
+24%
-0.46
-21%
-0.38
+17%
-0.16
+58%
-0.01
+94%
-0.04
-300%
-0.1
-150%
0
N/A
-0.05
N/A
-0.06
-20%
-0.06
N/A
-0.07
-17%
-0.04
+43%
-0.06
-50%
-0.06
N/A
-0.05
+17%
-0.06
-20%
-0.08
-33%
-0.08
N/A
-0.03
+63%
-0.05
-67%
-0.06
-20%
-0.03
+50%
-0.04
-33%
-0.07
-75%
-0.1
-43%
-0.09
+10%
-0.05
+44%
-0.05
N/A
-0.05
N/A
-0.04
+20%
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett